Cargando…

World Association for Sarcoidosis and Other Granulomatous Disease (WASOG) Centers of Excellence

Detalles Bibliográficos
Autores principales:	Baughman, Robert P, Grutters, Jan C, Wells, Athol U, Azuma, Arata, Costabel, Ulrich, Drent, Marjolein, Lower, Elyse E, Culver, Daniel A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787373/ https://www.ncbi.nlm.nih.gov/pubmed/35115756 http://dx.doi.org/10.36141/svdld.v38i4.12620

Ejemplares similares

WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension
por: Savale, Laurent, et al.
Publicado: (2022)

When the Game Changes: Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 Pandemic
por: Sweiss, Nadera J., et al.
Publicado: (2020)

Methotrexate in sarcoidosis: hematologic and hepatic toxicity encountered in a large cohort over a six year period
por: Baughman, Robert P., et al.
Publicado: (2020)

Goldilocks, vitamin D and sarcoidosis
por: Baughman, Robert P, et al.
Publicado: (2014)

COVID-19 infections in sarcoidosis: a prospective single center study of 886 sarcoidosis patients
por: Baughman, Robert P., et al.
Publicado: (2021)

Rituximab for refractory granulomatous eye disease
por: Lower, Elyse E, et al.
Publicado: (2012)

Echocardiographic estimate of pulmonary artery pressure in sarcoidosis patients - real world data from a multi-national study
por: Huitema, Marloes P, et al.
Publicado: (2021)

Dual Medical Therapy for Treatment of Arrhythmias in Cardiac Sarcoidosis
por: Sibilia, Robert, et al.
Publicado: (2022)

Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis
por: Rahaghi, Franck F., et al.
Publicado: (2020)

Accuracy of Serial PET-CT Imaging in Systemic Sarcoidosis
por: Carbone, Roberto G., et al.
Publicado: (2014)

Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel
por: Zhou, Ying, et al.
Publicado: (2015)

COVID-19 and Sarcoidosis, Readiness for Vaccination: Challenges and Opportunities
por: Manansala, Michael, et al.
Publicado: (2021)

Roflumilast (Daliresp®) to reduce acute pulmonary events in fibrotic sarcoidosis: a multi-center, double blind, placebo controlled, randomized clinical trial
por: Baughman, Robert P, et al.
Publicado: (2021)

Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire
por: Baughman, Robert P., et al.
Publicado: (2020)

Repository corticotropin for Chronic Pulmonary Sarcoidosis
por: Baughman, Robert P., et al.
Publicado: (2017)

Clinical characteristics of sarcoidosis patients in the United States versus China
por: Zhou, Ying, et al.
Publicado: (2017)

A Case Demonstrating the Pathological Relationship between Granulomatous Vasculitis and Glomerular Lesion in Renal Sarcoidosis
por: Kamata, Yoshinori, et al.
Publicado: (2020)

SACE and IL-2R as serum biomarkers for evaluation of multi-organ involvement and prognosis of sarcoidosis
por: Zhou, Ying, et al.
Publicado: (2023)

Initial behaviors and attitudes towards the COVID-19 vaccine in sarcoidosis patients: Results of a self-reporting questionnaire
por: Vagts, Christen, et al.
Publicado: (2023)

Granulomatous Sarcoidosis Mimics
por: Judson, Marc A.
Publicado: (2021)

Efzofitimod: a novel anti-inflammatory agent for sarcoidosis
por: Baughman, Robert P., et al.
Publicado: (2023)

Granulomatous Lithiasic Cholecystitis in Sarcoidosis
por: Handra-Luca, Adriana
Publicado: (2016)

Comorbidities of sarcoidosis
por: Tana, Claudio, et al.
Publicado: (2022)

Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes
por: Saketkoo, Lesley Ann, et al.
Publicado: (2021)

Activity tracking devices in sarcoidosis
por: Klein, Rebecca A., et al.
Publicado: (2023)

The Role of Diverse Immune Cells in Sarcoidosis
por: Zhang, Hui, et al.
Publicado: (2021)

Benefit of Wearing an Activity Tracker in Sarcoidosis
por: Drent, Marjolein, et al.
Publicado: (2020)

Drug-induced comorbidities in patients with sarcoidosis
por: Drent, Marjolein, et al.
Publicado: (2022)

The Burden of Sarcoidosis Symptoms from a Patient Perspective
por: Voortman, M., et al.
Publicado: (2019)

Identifying a core outcome set for pulmonary sarcoidosis research – the Foundation for Sarcoidosis Research – Sarcoidosis Clinical OUtcomes Taskforce (SCOUT)
por: Harman, Nicola L., et al.
Publicado: (2022)

Correction to: The Burden of Sarcoidosis Symptoms from a Patient Perspective
por: Voortman, M., et al.
Publicado: (2019)

Infection prevention in sarcoidosis: proposal for vaccination and prophylactic therapy
por: Syed, Huzaefah, et al.
Publicado: (2020)

LETTER TO THE EDITOR Atypical Granulomatous Myositis and Pulmonary Sarcoidosis
por: Scalco, Renata Siciliani, et al.
Publicado: (2015)

Granulomatous-Lymphocytic Interstitial Lung Disease Mimicking Sarcoidosis
por: Perlman, David M, et al.
Publicado: (2021)

Management of neurosarcoidosis: a clinical challenge
por: Voortman, Mareye, et al.
Publicado: (2019)

Sarcoidosis in a patient clinically diagnosed with silicosis; is silica associated sarcoidosis a new phenotype?
por: Beijer, Els, et al.
Publicado: (2019)

Scout – sarcoidosis outcomes taskforce. A systematic review of outcomes to inform the development of a core outcome set for pulmonary sarcoidosis
por: Harman, Nicola L, et al.
Publicado: (2021)

Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study
por: Rahaghi, Franck F., et al.
Publicado: (2020)

A Rare Case Study About Necrotizing Granulomatous Sarcoidosis
por: Tasleem, Azka, et al.
Publicado: (2020)

First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiative
por: Kampstra, Nynke A, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mcrimqllunhdhq51182p82rv5b